Want to see HK:0950 full AI Analyst Report?
Lee's Pharmaceutical Holdings Limited (0950) Financial Statements
Lee's Pharmaceutical Holdings Limited Financial Overview
Lee's Pharmaceutical Holdings Limited's market cap is currently $606.50M. The company's EPS TTM is $0.28; its P/E ratio is 3.64; and it has a dividend yield of 5.61%. Lee's Pharmaceutical Holdings Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.44B | $ 1.40B | $ 1.05B | $ 1.23B | $ 1.27B |
| Gross Profit | $ 729.56M | $ 753.36M | $ 551.31M | $ 770.75M | $ 806.28M |
| Operating Income | $ 85.96M | $ 113.14M | $ 43.55M | $ 76.56M | $ 1.98B |
| EBITDA | $ 265.93M | $ 260.87M | $ 193.05M | $ 229.06M | $ 2.13B |
| Net Income | $ 91.94M | $ 93.10M | $ 16.70M | $ 51.28M | $ 1.99B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 349.90M | $ 216.84M | $ 171.00M | $ 189.30M | $ 277.53M |
| Total Assets | $ 3.46B | $ 2.62B | $ 2.89B | $ 2.78B | $ 3.64B |
| Total Debt | $ 310.27M | $ 227.30M | $ 204.14M | $ 163.49M | $ 267.14M |
| Net Debt | $ -39.63M | $ 10.45M | $ 33.14M | $ -25.81M | $ -10.39M |
| Total Liabilities | $ 1.56B | $ 1.07B | $ 930.07M | $ 939.50M | $ 1.25B |
| Stockholders' Equity | $ 2.05B | $ 1.65B | $ 2.04B | $ 1.92B | $ 2.46B |
| Cash Flow | |||||
| Free Cash Flow | $ 101.35M | $ 34.45M | $ -49.63M | $ 69.81M | $ -160.04M |
| Operating Cash Flow | $ 332.90M | $ 242.01M | $ 110.08M | $ 283.63M | $ 210.68M |
| Investing Cash Flow | $ -235.76M | $ -190.23M | $ -145.22M | $ -256.05M | $ -370.28M |
| Financing Cash Flow | $ 35.58M | $ -1.96M | $ 13.44M | $ -128.60M | $ 60.97M |
Currency in HKD